↑ ↓ Navigate ↡ Select ESC Close

The 60-Year Cholesterol War Is Finally Over

2026-04-16 People & Blogs
45.7k
2.6k
636
Dr Brad Stanfield
Dr Brad Stanfield
328.0k subscribers

Unlock all features

FREE: Get instant access to 10 AI summaries, chats, or transcripts per day.

Description

🩺 Get your personalized health plan: https://drstanfield.com/pages/roadmap πŸ’Š Supplements I Take: https://drstanfield.com/pages/my-supplements πŸ’ŠMicroVitamin+ (Pro) Powder: https://drstanfield.com/products/microvitamin-plus πŸ’ŠMicroVitamin Standard Capsules: https://drstanfield.com/products/microvitamin βœ”οΈ X: https://x.com/BradStanfieldMD βœ”οΈ Patreon: https://www.patreon.com/bradstanfieldmd Timestamps: 00:00 The Dallas Heart Study and PCSK9 02:58 The Fourier Trial 03:34 The VESALIUS-CV Trial 08:21 The Case for Lower LDL Targets 08:26 The Ez-PAVE Study 10:13 The PESA Study 11:53 The Underutilization of Ezetimibe 13:22 Conclusion and Future Directions Here are the links to the research papers referenced in the video: 1. doi: 10.1001/jama.2026.3277 https://jamanetwork.com/journals/jama/fullarticle/2847162 VESALIUS-CV Diabetes Subgroup Analysis β€” JAMA 2026 2. doi: 10.1172/JCI84086 https://pmc.ncbi.nlm.nih.gov/articles/PMC4607136/ JCI Conversation with Helen Hobbs β€” 2015 3. doi: 10.1056/NEJMoa054013 https://www.nejm.org/doi/full/10.1056/NEJMoa054013 Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease β€” NEJM 2006 4. doi: 10.3389/fcvm.2021.764038 https://pmc.ncbi.nlm.nih.gov/articles/PMC8589637/ Regulation of PCSK9 Expression and Function: Mechanisms and Therapeutic Implications β€” Frontiers in Cardiovascular Medicine 2021 5. doi: 10.1016/j.jacc.2012.08.986 https://www.jacc.org/doi/10.1016/j.jacc.2012.08.986 Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels β€” JACC 2012 6. doi: 10.1056/NEJMoa1615664 https://www.nejm.org/doi/full/10.1056/NEJMoa1615664 Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease (FOURIER) β€” NEJM 2017 7. doi: 10.1056/NEJMoa2514428 https://www.nejm.org/doi/full/10.1056/NEJMoa2514428 Evolocumab in Patients without a Previous Myocardial Infarction or Stroke (VESALIUS-CV) β€” NEJM 2025 8. https://www.acc.org/About-ACC/Press-Releases/2026/03/28/15/33/Evolocumab-Cuts-Cardiac-Risk-in-Patients-Without-Known-Atherosclerosis-and-With-Diabetes Evolocumab Cuts Cardiac Risk in Patients Without Known Atherosclerosis and With Diabetes β€” ACC Press Release, March 2026 9. https://www.peoplespharmacy.com/articles/woman-has-heart-attack-despite-very-low-cholesterol Woman Has Heart Attack Despite Very Low Cholesterol β€” People's Pharmacy 10. doi: 10.1016/j.ahj.2008.08.010 https://pubmed.ncbi.nlm.nih.gov/19081406/ Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines β€” American Heart Journal 2009 11. doi: 10.1056/NEJMoa2600283 https://www.nejm.org/doi/full/10.1056/NEJMoa2600283 Ez-PAVE Trial β€” NEJM 2026 12. https://www.tctmd.com/news/very-low-ldl-levels-best-secondary-prevention-ez-pave Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE β€” TCTMD (Cannon + Aspry quotes) 13. doi: 10.1016/j.jacc.2017.10.024 https://www.jacc.org/doi/10.1016/j.jacc.2017.10.024 Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors (PESA) β€” JACC 2017 14. doi: 10.1177/11772719241257410 https://pmc.ncbi.nlm.nih.gov/articles/PMC11143858/ Are We Using Ezetimibe As Much As We Should? β€” Therapeutic Advances in Cardiovascular Disease 2024 15. doi: 10.1001/jama.2025.20620 https://jamanetwork.com/journals/jama/article-abstract/2841258 Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia β€” JAMA 2025 16. https://www.utsouthwestern.edu/newsroom/articles/year-2026/march-cholesterol-guideline-shifts-focus-earlier-prevention.html Updated cholesterol guideline shifts focus to earlier prevention β€” UT Southwestern Newsroom, March 2026 (Rohatgi quote) 17. doi: 10.1016/j.jacc.2012.09.017 https://www.jacc.org/doi/10.1016/j.jacc.2012.09.017 Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease β€” JACC 2012 Thumbnail by James Kelly Video edited by Troy Young Script by John Milliken The links above are affiliate links, so I receive a small commission every time you use them to purchase a product. The content contained in this video, and its accompanying description, is not intended to replace viewers’ relationships with their own medical practitioner. Always speak with your doctor regarding the content of this channel, and especially before using any products, services, or devices discussed on this channel.

Top Comments (10)

@tarlkudrick1174 2026-04-16

Oh, this war isn't over, Doctor. Medicine, like every other field, really only advances one funeral at a time.

32
@manofreedom 2026-04-16

It's not just LDL that's bad but specifically the sdLDL (small dense LDL) that is the atherogenic LDL. I order a "lipofit" or fractionated lipid panel on my patients along with lipoprotein "a" and apolipoprotein B/A1 ratios as well as HgA1C and C-reactive Protein. you can have a great LDL number of below 50 but if most of it is sdLDL then you are at increased risk of atherogenesis and if the lipoprotein "a" is high with a "good " LDL number of less than 50 your odds of developing atherogenesis are higher. I also look at the triglyceride to HDL ratio and if it's greater than 2 to 1 this is not good. Our diet of increased calories of highly processed carbs is causing terrible insulin resistance at a young age in the US and I'm seeing 10- and 12-year-old children with type two diabetes and obesity at an astounding rate. We are going to have an EXPLOSION of fatty liver disease and arterial vascular disease in only 10 to 20 years in these kids. The standard western diet and sedentary lifestyle is killing us. Insulin resistance is the main causative issue that causes fatty liver and the oxidized (free radicalized) sdLDL to stay in circulation long enough to damage the lining of the arteries and thus atherogenesis. LDL in and of itself is not the problem but what causes the high sdLDL is the issue.

31 13 replies
@CessSim 2026-04-17

Why do people keep focusing on Lipids? Associative not causative. Millions of years of human evolution and our body produces something that is designed to kill us. Don't think so. Get metabolically healthy first. Try that.....

10
@Overthere_World 2026-04-17

More and more experiments are yielding completely different conclusions, making people increasingly confused.

4
@DrBradStanfield 2026-04-16

🩺 Get your personalized health plan: https://drstanfield.com/pages/roadmap Diet comes first. Supplements are a distant afterthought. That said, there's one gap even a great diet struggles to close consistently: hitting optimal micronutrient intake every day. That's why I created MicroVitamin to complement (not replace) a healthy diet: https://drstanfield.com/products/microvitamin

2 5 replies
@DuncanWalshover40workouts 2026-04-16

Enjoyed the talk as usual

2
@kapurar 2026-04-16

Great information that is fantastically presented! Really appreciate your channel and the information you share. Cheers! πŸ‡¨πŸ‡¦

2
@olyav5819 2026-04-16

Thanks for the update!

2
@toddboothbee1361 2026-04-16

Thanks for the great information and the few pleonasms.

1
@joselopez-cu7gh 2026-04-16

Thanks doc

0

Unlock the Data Inside
Turn Videos into Knowledge

  • Get FREE 10/day: transcripts, summaries, chats
  • Chat with videos, export text & PDF
  • $1 free API credit for RAG, chatbots & research

Free forever plan β€’ All features unlocked

App screenshot